Parkinson's Disease

Researcher: 
Dr. Andres M Luzano

Parkinson’s is a devastating disease and one of the most common nervous system disorders of the elderly. It often develops after the age of 50, but can affect young people if the disease runs in the family.

 However, there is some hope. IMRIC and the University of Toronto are leading the way in the exploration of new techniques to treat Parkinson’s. It is their hope that one day ways to prevent the disease will be found. 

 
Collaborative Projects

Parkinson's Disease Research

Jerusalem/Toronto

IMRIC researcher Prof. Hagai Bergman, a pioneer in the development of treatment for Parkinson's and other movement disorders, has teamed up with senior scientist Dr. Andres Luzano of Toronto Western Hospital. 

Latest News

Helping the blind to “see” with their acute sense of hearing, treating schizophrenia patients by electrically stimulating tissue deep in their head, and giving the sense of feeling to those without limbs are all part of the wave of the future in brain science, presented by Israeli and foreign researchers at the Presidential Conference in Jerusalem.

A new method for dynamic, electronic deep brain stimulation (DBS) developed at the Hebrew University of Jerusalem offers promise for better treatment of the symptoms of Parkinson’s disease.

 

Israeli researchers at The Institute for Medical Research Israel-Canada (IMRIC) at Hebrew U say a new material they are developing that inhibits the aging process could prevent degenerative diseases without affecting lifespan.

Related Videos

Dr. Hagai Bergman, IMRIC Researcher, Basal Ganglia Research Laboratory - 1 of 3

Your rating: None Average: 4.3 (3 votes)

The Hebrew University of Jerusalem - Preserving Memory, Building Israel, Changing The World

Your rating: None Average: 5 (1 vote)

Canadian Impact at Hebrew University - A Spotlight on IMRIC

No votes yet